Ermann J, Szanya V, Ford G S, Paragas V, Fathman C G, Lejon K
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Immunol. 2001 Oct 15;167(8):4271-5. doi: 10.4049/jimmunol.167.8.4271.
T cell anergy is characterized by the inability of the T cell to produce IL-2 and proliferate. It is reversible by the addition of exogenous IL-2. A similar state of unresponsiveness is observed when the proliferative response of murine CD4(+)CD25(-) T cells is suppressed in vitro by coactivated CD4(+)CD25(+) T cells. We have developed a suppression system that uses beads coated with anti-CD3 and anti-CD28 Abs as surrogate APCs to study the interaction of CD4(+)CD25(+) and CD4(+)CD25(-) T cells in vitro. CD4(+)CD25(+) T cell-induced suppression, in this model, was not abrogated by blocking the B7-CTLA-4 pathway. When the CD4(+)CD25(-) T cells were separated from the CD4(+)CD25(+) suppressor cells after 24 h of coactivation by the Ab-coated beads, the CD4(+)CD25(-) T cells were unable to proliferate or to produce IL-2 upon restimulation. The induction of this anergic phenotype in the CD4(+)CD25(-) T cells correlated with the up-regulated expression of the gene related to anergy in lymphocytes (GRAIL), a novel anergy-related gene that acts as a negative regulator of IL-2 transcription. This system constitutes a novel mechanism of anergy induction in the presence of costimulation.
T细胞无能的特征在于T细胞无法产生白细胞介素-2(IL-2)并进行增殖。通过添加外源性IL-2可使其逆转。当小鼠CD4(+)CD25(-) T细胞的增殖反应在体外被共激活的CD4(+)CD25(+) T细胞抑制时,会观察到类似的无反应状态。我们开发了一种抑制系统,该系统使用包被有抗CD3和抗CD28抗体的珠子作为替代抗原呈递细胞(APCs),以在体外研究CD4(+)CD25(+)和CD4(+)CD25(-) T细胞之间的相互作用。在该模型中,CD4(+)CD25(+) T细胞诱导的抑制作用不会因阻断B7-细胞毒性T淋巴细胞相关抗原4(CTLA-4)途径而消除。当用抗体包被的珠子共激活24小时后,将CD4(+)CD25(-) T细胞与CD4(+)CD25(+)抑制细胞分离,再刺激时,CD4(+)CD25(-) T细胞无法增殖或产生IL-2。CD4(+)CD25(-) T细胞中这种无能表型的诱导与淋巴细胞中与无能相关基因(GRAIL)的表达上调相关,GRAIL是一种新的与无能相关的基因,作为IL-2转录的负调节因子。该系统构成了在共刺激存在下无能诱导的新机制。